Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 1
1982 3
1983 3
1984 1
1985 5
1986 10
1987 12
1988 13
1989 16
1990 16
1991 21
1992 30
1993 38
1994 39
1995 52
1996 59
1997 62
1998 76
1999 74
2000 103
2001 88
2002 115
2003 139
2004 178
2005 219
2006 265
2007 285
2008 331
2009 402
2010 416
2011 542
2012 648
2013 756
2014 923
2015 1013
2016 1097
2017 1191
2018 1295
2019 1548
2020 1877
2021 805
Text availability
Article attribute
Article type
Publication date

Search Results

13,201 results
Results by year
Filters applied: . Clear all
Page 1
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial.
Zhou C, Chen G, Huang Y, Zhou J, Lin L, Feng J, Wang Z, Shu Y, Shi J, Hu Y, Wang Q, Cheng Y, Wu F, Chen J, Lin X, Wang Y, Huang J, Cui J, Cao L, Liu Y, Zhang Y, Pan Y, Zhao J, Wang L, Chang J, Chen Q, Ren X, Zhang W, Fan Y, He Z, Fang J, Gu K, Dong X, Zhang T, Shi W, Zou J; CameL Study Group. Zhou C, et al. Among authors: lin x. Lancet Respir Med. 2021 Mar;9(3):305-314. doi: 10.1016/S2213-2600(20)30365-9. Epub 2020 Dec 18. Lancet Respir Med. 2021. PMID: 33347829 Clinical Trial.
Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy.
Zhou C, Wang Y, Zhao J, Chen G, Liu Z, Gu K, Huang M, He J, Chen J, Ma Z, Feng J, Shi J, Yu X, Cheng Y, Yao Y, Chen Y, Guo R, Lin X, Wang Z, Gao G, Wang Q, Li W, Yang X, Wu L, Zhang J, Ren S. Zhou C, et al. Among authors: lin x. Clin Cancer Res. 2021 Mar 1;27(5):1296-1304. doi: 10.1158/1078-0432.CCR-20-3136. Epub 2020 Dec 15. Clin Cancer Res. 2021. PMID: 33323401
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy.
Gromeier M, Brown MC, Zhang G, Lin X, Chen Y, Wei Z, Beaubier N, Yan H, He Y, Desjardins A, Herndon JE 2nd, Varn FS, Verhaak RG, Zhao J, Bolognesi DP, Friedman AH, Friedman HS, McSherry F, Muscat AM, Lipp ES, Nair SK, Khasraw M, Peters KB, Randazzo D, Sampson JH, McLendon RE, Bigner DD, Ashley DM. Gromeier M, et al. Among authors: lin x. Nat Commun. 2021 Jan 13;12(1):352. doi: 10.1038/s41467-020-20469-6. Nat Commun. 2021. PMID: 33441554 Free PMC article.
Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer.
Zhao J, Lin X, Meng D, Zeng L, Zhuang R, Huang S, Lv W, Hu J. Zhao J, et al. Among authors: lin x. Front Oncol. 2020 Nov 26;10:578315. doi: 10.3389/fonc.2020.578315. eCollection 2020. Front Oncol. 2020. PMID: 33324555 Free PMC article. Review.
MiR-548d-3p Promotes Gastric Cancer by Targeting RSK4.
Liang H, Hu C, Lin X, He Z, Lin Z, Dai J. Liang H, et al. Among authors: lin x. Cancer Manag Res. 2020 Dec 24;12:13325-13337. doi: 10.2147/CMAR.S278691. eCollection 2020. Cancer Manag Res. 2020. PMID: 33380838 Free PMC article.
13,201 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page